CN102603845B - 合成与分离植物甾醇饱和脂肪酸酯和不饱和脂肪酸酯的方法 - Google Patents
合成与分离植物甾醇饱和脂肪酸酯和不饱和脂肪酸酯的方法 Download PDFInfo
- Publication number
- CN102603845B CN102603845B CN201210019987.2A CN201210019987A CN102603845B CN 102603845 B CN102603845 B CN 102603845B CN 201210019987 A CN201210019987 A CN 201210019987A CN 102603845 B CN102603845 B CN 102603845B
- Authority
- CN
- China
- Prior art keywords
- fatty acid
- acid
- plant sterol
- acid esters
- phytosterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 saturated fatty acid esters Chemical class 0.000 title claims abstract description 33
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 17
- 230000002194 synthesizing effect Effects 0.000 title abstract description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 69
- 238000004821 distillation Methods 0.000 claims abstract description 17
- 238000005406 washing Methods 0.000 claims abstract description 16
- 238000000199 molecular distillation Methods 0.000 claims abstract description 10
- 238000001704 evaporation Methods 0.000 claims abstract description 9
- 230000008020 evaporation Effects 0.000 claims abstract description 9
- 239000012065 filter cake Substances 0.000 claims abstract description 9
- 239000000706 filtrate Substances 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 235000002378 plant sterols Nutrition 0.000 claims description 70
- 239000002253 acid Substances 0.000 claims description 49
- 150000002632 lipids Chemical class 0.000 claims description 47
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 39
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 24
- 150000002148 esters Chemical class 0.000 claims description 19
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 14
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 claims description 14
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 12
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 12
- JXAZAUKOWVKTLO-UHFFFAOYSA-L sodium pyrosulfate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)OS([O-])(=O)=O JXAZAUKOWVKTLO-UHFFFAOYSA-L 0.000 claims description 12
- 229940076810 beta sitosterol Drugs 0.000 claims description 10
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims description 10
- 229950005143 sitosterol Drugs 0.000 claims description 10
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims description 9
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 8
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 8
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 8
- 239000005642 Oleic acid Substances 0.000 claims description 8
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 8
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 8
- 239000010409 thin film Substances 0.000 claims description 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 7
- 229960004232 linoleic acid Drugs 0.000 claims description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 7
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 7
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 6
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 claims description 6
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 claims description 6
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 claims description 6
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 claims description 6
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims description 6
- 235000004420 brassicasterol Nutrition 0.000 claims description 6
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 claims description 6
- 235000000431 campesterol Nutrition 0.000 claims description 6
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 6
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims description 6
- 235000016831 stigmasterol Nutrition 0.000 claims description 6
- 229940032091 stigmasterol Drugs 0.000 claims description 6
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims description 6
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 5
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 5
- 239000008117 stearic acid Substances 0.000 claims description 5
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- 239000005639 Lauric acid Substances 0.000 claims description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 claims description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 2
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 claims description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 2
- 229960002733 gamolenic acid Drugs 0.000 claims description 2
- 235000021003 saturated fats Nutrition 0.000 claims description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 14
- 238000006243 chemical reaction Methods 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 6
- 239000000047 product Substances 0.000 abstract description 6
- 235000012000 cholesterol Nutrition 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 230000009467 reduction Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 4
- 229940075999 phytosterol ester Drugs 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000013517 stratification Methods 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical group [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 2
- 239000000292 calcium oxide Substances 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ZXGIHLGVUYXAEI-QXKOIZLYSA-N [(3s,8s,9s,10r,13r,14s,17r)-17-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] octadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CC[C@@H](CC)C(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 ZXGIHLGVUYXAEI-QXKOIZLYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940040452 linolenate Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-M linolenate Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC([O-])=O DTOSIQBPPRVQHS-PDBXOOCHSA-M 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210019987.2A CN102603845B (zh) | 2012-01-21 | 2012-01-21 | 合成与分离植物甾醇饱和脂肪酸酯和不饱和脂肪酸酯的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210019987.2A CN102603845B (zh) | 2012-01-21 | 2012-01-21 | 合成与分离植物甾醇饱和脂肪酸酯和不饱和脂肪酸酯的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102603845A CN102603845A (zh) | 2012-07-25 |
CN102603845B true CN102603845B (zh) | 2014-10-22 |
Family
ID=46521666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210019987.2A Active CN102603845B (zh) | 2012-01-21 | 2012-01-21 | 合成与分离植物甾醇饱和脂肪酸酯和不饱和脂肪酸酯的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102603845B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104087425B (zh) * | 2014-07-08 | 2016-05-11 | 龚旌 | 一种低成本共轭亚油酸的制备方法 |
CN104262444B (zh) * | 2014-09-03 | 2016-09-14 | 陕西海斯夫生物工程有限公司 | 一种植物甾醇脂肪酸酯及其催化合成方法 |
CN105001083B (zh) * | 2015-07-31 | 2017-05-03 | 宜春大海龟生命科学有限公司 | 植物甾醇油酸酯的制备方法 |
CN107955054A (zh) * | 2017-11-30 | 2018-04-24 | 陕西海斯夫生物工程有限公司 | 一种薄膜反应与分离耦合制备植物甾醇酯的方法 |
CN108531538A (zh) * | 2018-04-08 | 2018-09-14 | 武汉藤欣生物工程有限公司 | 一种酶法制备植物甾醇酯的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5502045A (en) * | 1991-05-03 | 1996-03-26 | Raision Tehtaat Oy Ab | Use of a stanol fatty acid ester for reducing serum cholesterol level |
US5892068A (en) * | 1998-08-25 | 1999-04-06 | Mcneil-Ppc, Inc. | Preparation of sterol and stanol-esters |
CN1251837A (zh) * | 1998-08-25 | 2000-05-03 | 麦克尼尔-Ppc公司 | 固醇酯和固烷醇酯的制备方法 |
CN101985460A (zh) * | 2010-08-10 | 2011-03-16 | 江南大学 | 一种植物甾醇酯的制备方法 |
CN102190700A (zh) * | 2010-03-12 | 2011-09-21 | 丰益(上海)生物技术研发中心有限公司 | 一种脂肪酸植物甾醇酯制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110059188A (ko) * | 2009-11-27 | 2011-06-02 | 주식회사 한국발보린 | 피토스테롤 에스테르의 제조 방법 |
-
2012
- 2012-01-21 CN CN201210019987.2A patent/CN102603845B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5502045A (en) * | 1991-05-03 | 1996-03-26 | Raision Tehtaat Oy Ab | Use of a stanol fatty acid ester for reducing serum cholesterol level |
US5892068A (en) * | 1998-08-25 | 1999-04-06 | Mcneil-Ppc, Inc. | Preparation of sterol and stanol-esters |
CN1251837A (zh) * | 1998-08-25 | 2000-05-03 | 麦克尼尔-Ppc公司 | 固醇酯和固烷醇酯的制备方法 |
CN102190700A (zh) * | 2010-03-12 | 2011-09-21 | 丰益(上海)生物技术研发中心有限公司 | 一种脂肪酸植物甾醇酯制备方法 |
CN101985460A (zh) * | 2010-08-10 | 2011-03-16 | 江南大学 | 一种植物甾醇酯的制备方法 |
Non-Patent Citations (6)
Title |
---|
植物甾醇油酸酯产品的合成工艺研究;陈茂彬;《中国油脂》;20050630;第30卷(第6期);第63-65页 * |
植物甾醇硬脂酸酯的合成研究;陈茂彬 等;《湖北工业大学学报》;20050228;第20卷(第1期);第1-3页 * |
植物甾醇酯的制备、生物活性及应用研究;陈茂彬;《华中农业大学博士学位论文》;20060331;第9-10、39-55页 * |
陈茂彬 等.植物甾醇硬脂酸酯的合成研究.《湖北工业大学学报》.2005,第20卷(第1期),第1-3页. |
陈茂彬.植物甾醇油酸酯产品的合成工艺研究.《中国油脂》.2005,第30卷(第6期),第63-65页. |
陈茂彬.植物甾醇酯的制备、生物活性及应用研究.《华中农业大学博士学位论文》.2006,第9-10、39-55页. |
Also Published As
Publication number | Publication date |
---|---|
CN102603845A (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102603845B (zh) | 合成与分离植物甾醇饱和脂肪酸酯和不饱和脂肪酸酯的方法 | |
US6828451B2 (en) | Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry | |
CA2595917C (en) | Method for producing a dha-containing fatty acid composition | |
CN101985460B (zh) | 一种植物甾醇酯的制备方法 | |
CN101845473A (zh) | 一种高效合成植物甾醇酯的方法 | |
CN104186705A (zh) | 基于酶促酸解棕榈酸甘油三酯合成结构脂质的方法 | |
CN107216252A (zh) | 一种高含量Omega-3脂肪酸乙酯的制备方法 | |
WO2007111276A1 (ja) | 新規エステル誘導体およびその用途 | |
CN110257446B (zh) | 一种高纯度epa甘油酯和dha甘油酯的制备方法 | |
JP5733696B2 (ja) | 脂肪分解作用を呈するカロチノイド誘導体の製造方法 | |
CN101161819A (zh) | 一种酶法制备n-3PUFA海洋甘油酯的方法 | |
CN103445996A (zh) | 一种从乳木果液态油中提取不皂化物的方法 | |
CN100441559C (zh) | 石榴酸及其盐和酯的制备方法 | |
CN101525558A (zh) | 蜂花粉中功能性多不饱和脂肪酸的制备工艺 | |
CN106822081A (zh) | 一种磷脂型石榴酸油脂组合物及其制备方法和应用 | |
CN106397384A (zh) | 一种大环麝香内酯的合成方法 | |
CN102628003A (zh) | 一种从亚麻油中提取纯化α-亚麻酸的方法 | |
CN1223664C (zh) | 从鱼油中提纯高含量dha、epa的方法 | |
CN100500632C (zh) | 尿素柱层析生产亚麻酸和亚麻酸低级酯的方法 | |
CN113413342B (zh) | 一种从澳洲坚果中提取棕榈油酸的方法及其应用 | |
CN102229856B (zh) | 一种猕猴桃籽油及其制备方法 | |
JP2001097983A (ja) | スフィンゴ脂質を含有する植物抽出物およびその製造方法 | |
CN107955054A (zh) | 一种薄膜反应与分离耦合制备植物甾醇酯的方法 | |
CN108796023A (zh) | 一种高纯度植物甾醇单体酯的制备方法 | |
KR102140333B1 (ko) | 높은 피부미백효과를 지닌 고농도 유리 감마-리놀렌산을 포함하는 효소처리 식물성 오일, 이의 제조방법 및 이를 포함하는 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing and separating phytosterol saturated fatty acid esters and phytosterol unsaturated fatty acid esters Effective date of registration: 20151130 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: 2015990001062 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170412 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: 2015990001062 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing and separating phytosterol saturated fatty acid esters and phytosterol unsaturated fatty acid esters Effective date of registration: 20170412 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: 2017990000302 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20171215 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: 2017990000302 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing and separating phytosterol saturated fatty acid esters and phytosterol unsaturated fatty acid esters Effective date of registration: 20171215 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: 2017990001180 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20181113 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: 2017990001180 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing and separating phytosterol saturated fatty acid esters and phytosterol unsaturated fatty acid esters Effective date of registration: 20181113 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: 2018990001057 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191111 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: 2018990001057 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing and separating phytosterol saturated fatty acid esters and phytosterol unsaturated fatty acid esters Effective date of registration: 20191111 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2019990000494 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210106 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2019990000494 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Synthesis and separation of phytosterol saturated fatty acid esters and unsaturated fatty acid esters Effective date of registration: 20210106 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021990000004 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211213 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021990000004 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for synthesizing and separating plant sterol saturated fatty acid ester and unsaturated fatty acid ester Effective date of registration: 20220126 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022610000004 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220908 Granted publication date: 20141022 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022610000004 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Methods for synthesis and separation of phytosterol saturated fatty acid ester and unsaturated fat acid ester Effective date of registration: 20230517 Granted publication date: 20141022 Pledgee: China Minsheng Banking Corp Xi'an branch Pledgor: XI'AN HEALTHFUL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023610000376 |